Generated on: This page was generated by TSDR on 2017-08-10 11:39:33 EDT
`
`Mark: CINRYZE
`
`US Serial Number: 77212428
`
`US Registration
`Number:
`
`3867834
`
`Register: Principal
`
`Mark Type: Trademark
`
`Application Filing
`Date:
`
`Jun. 21, 2007
`
`Registration Date: Oct. 26, 2010
`
`Status: A Sections 8 and 15 combined declaration has been accepted and acknowledged.
`
`Status Date: Sep. 26, 2016
`
`Publication Date: Jun. 10, 2008
`
`Mark Literal
`Elements:
`
`CINRYZE
`
`Notice of
`Allowance Date:
`
`Sep. 02, 2008
`
`Mark Information
`
`Standard Character
`Claim:
`
`Mark Drawing
`Type:
`
`Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
`
`4 - STANDARD CHARACTER MARK
`
`Related Properties Information
`
`1307249
`
`A0059770/1307249
`
`International
`Registration
`Number:
`
`International
`Application(s)
`/Registration(s)
`Based on this
`Property:
`
`Goods and Services
`
`Note: The following symbols indicate that the registrant/owner has amended the goods/services:
`
`Brackets [..] indicate deleted goods/services;
`Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit of incontestability; and
`Asterisks *..* identify additional (new) wording in the goods/services.
`
`For: pharmaceutical preparations for the treatment of conditions associated with inflammatory processes, namely, hereditary angioedema
`
`International
`Class(es):
`
`005 - Primary Class
`
`Class Status: ACTIVE
`
`Basis: 1(a)
`
`First Use: Nov. 20, 2008
`
`U.S Class(es): 006, 018, 044, 046, 051, 052
`
`Use in Commerce: Nov. 20, 2008
`Basis Information (Case Level)
`
`Filed Use: No
`
`Filed ITU: Yes
`
`Filed 44D: No
`
`Filed 44E: No
`
`Filed 66A: No
`
`Currently Use: Yes
`
`Currently ITU: No
`
`Currently 44D: No
`
`Currently 44E: No
`
`Currently 66A: No
`
`Amended Use: No
`
`Amended ITU: No
`
`Amended 44D: No
`
`Amended 44E: No
`
` 
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 1
`
`

`

`Filed No Basis: No
`
`Currently No Basis: No
`Current Owner(s) Information
`
`Owner Name: VIROPHARMA BIOLOGICS, INC.
`
`Owner Address: 300 Shire Way
`LEXINGTON, MASSACHUSETTS 02421
`UNITED STATES
`
`Legal Entity Type: CORPORATION
`
`State or Country
`Where Organized:
`Attorney/Correspondence Information
`
`DELAWARE
`
`Attorney Name: Timothy H. Hiebert
`
`Attorney Primary
`Email Address:
`
`hiebert@samuelsTM.com
`
`Correspondent
`Name/Address:
`
`Timothy H. Hiebert
`Samuels & Hiebert LLC
`Two International Place, 23rd Floor
`Boston, MASSACHUSETTS 02110-4104
`UNITED STATES
`
`Phone: 617-426-5553
`
`Correspondent e-
`mail:
`
`hiebert@samuelsTM.com
`
`Attorney of Record
`Docket Number: 041492.0057.
`
`Attorney Email
`Authorized:
`
`Yes
`
`Correspondent
`
`Fax: 617-507-2449
`
`Correspondent e-
`mail Authorized:
`
`Yes
`
`Domestic Representative - Not Found
`Prosecution History
`
`Date
`
`Description
`
`Sep. 26, 2016
`Sep. 26, 2016
`Sep. 26, 2016
`Jul. 20, 2016
`Oct. 26, 2015
`Sep. 03, 2015
`Oct. 26, 2010
`Sep. 23, 2010
`Sep. 22, 2010
`Sep. 22, 2010
`Sep. 15, 2010
`Sep. 15, 2010
`Sep. 14, 2010
`Sep. 02, 2010
`Sep. 14, 2010
`Sep. 02, 2010
`Sep. 02, 2010
`Sep. 02, 2010
`Mar. 04, 2010
`Mar. 01, 2010
`Mar. 01, 2010
`Sep. 22, 2009
`Sep. 02, 2009
`Sep. 22, 2009
`Sep. 02, 2009
`Jul. 08, 2009
`Feb. 27, 2009
`
`NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
`REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
`CASE ASSIGNED TO POST REGISTRATION PARALEGAL
`TEAS SECTION 8 & 15 RECEIVED
`COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
`TEAS CHANGE OF CORRESPONDENCE RECEIVED
`REGISTERED-PRINCIPAL REGISTER
`NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
`LAW OFFICE REGISTRATION REVIEW COMPLETED
`ASSIGNED TO LIE
`ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
`NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
`STATEMENT OF USE PROCESSING COMPLETE
`USE AMENDMENT FILED
`EXTENSION 4 GRANTED
`EXTENSION 4 FILED
`TEAS EXTENSION RECEIVED
`TEAS STATEMENT OF USE RECEIVED
`EXTENSION 3 GRANTED
`EXTENSION 3 FILED
`TEAS EXTENSION RECEIVED
`EXTENSION 2 GRANTED
`EXTENSION 2 FILED
`CASE ASSIGNED TO INTENT TO USE PARALEGAL
`TEAS EXTENSION RECEIVED
`ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
`EXTENSION 1 GRANTED
`
`Proceeding
`Number
`
`70132
`70132
`
`67287
`67287
`
`61813
`61813
`61813
`61813
`
`61813
`61813
`
`61813
`61813
`61813
`
`98765
`
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 2
`
`

`

`Feb. 27, 2009
`Feb. 27, 2009
`Dec. 09, 2008
`Dec. 09, 2008
`Oct. 27, 2008
`Oct. 27, 2008
`Sep. 02, 2008
`Jun. 10, 2008
`May 21, 2008
`May 02, 2008
`May 02, 2008
`May 02, 2008
`Apr. 04, 2008
`Apr. 03, 2008
`Apr. 03, 2008
`Oct. 03, 2007
`Oct. 03, 2007
`Oct. 03, 2007
`Sep. 24, 2007
`Jun. 26, 2007
`
`EXTENSION 1 FILED
`TEAS EXTENSION RECEIVED
`ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
`TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
`ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
`TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
`NOA MAILED - SOU REQUIRED FROM APPLICANT
`PUBLISHED FOR OPPOSITION
`NOTICE OF PUBLICATION
`LAW OFFICE PUBLICATION REVIEW COMPLETED
`ASSIGNED TO LIE
`APPROVED FOR PUB - PRINCIPAL REGISTER
`TEAS/EMAIL CORRESPONDENCE ENTERED
`CORRESPONDENCE RECEIVED IN LAW OFFICE
`TEAS RESPONSE TO OFFICE ACTION RECEIVED
`NOTIFICATION OF NON-FINAL ACTION E-MAILED
`NON-FINAL ACTION E-MAILED
`NON-FINAL ACTION WRITTEN
`ASSIGNED TO EXAMINER
`NEW APPLICATION ENTERED IN TRAM
`Maintenance Filings or Post Registration Information
`
`98765
`
`78288
`78288
`
`88889
`88889
`
`6325
`6325
`78428
`78428
`
`Affidavit of
`Continued Use:
`
`Affidavit of
`Incontestability:
`
`Section 8 - Accepted
`
`Section 15 - Accepted
`
`TM Staff and Location Information
`
`TM Staff Information - None
`File Location
`Current Location: TMEG LAW OFFICE 107
`Date in Location: Sep. 26, 2016
`Assignment Abstract Of Title Information
`
`Summary
`
`Total Assignments: 6
`
`Conveyance: SECURITY INTEREST
`
`Reel/Frame: 3655/0663
`
`Date Recorded: Nov. 06, 2007
`
`Supporting
`Documents:
`
`assignment-tm-3655-0663.pdf
`
`Name: LEV PHARMACEUTICALS, INC.
`
`Legal Entity Type: CORPORATION
`
`Assignment 1 of 6
`
`Registrant: VIROPHARMA BIOLOGICS, INC.
`
`Pages: 7
`
`Assignor
`Execution Date: Nov. 02, 2007
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Assignee
`Name: MAST CAPITAL MANAGEMENT, LLC, AS COLLATERAL AGENT
`
`Legal Entity Type: LIMITED LIABILITY COMPANY
`
`State or Country
`Where Organized:
`
`No Place Where Organized Found
`
`Address: 535 BOYLTON STREET
`BOSTON, MASSACHUSETTS 02116
`
`Correspondent
`Name:
`
`ADAM M. GRANDY
`
`Correspondent
`
` 
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 3
`
`

`

`Correspondent
`Address:
`
`111 HUNTINGTON AVENUE
`EDWARDS ANGELL PALMER & DODGE LLP
`BOSTON, MA 02199
`
`Conveyance: RELEASE BY SECURED PARTY
`
`Reel/Frame: 3877/0582
`
`Date Recorded: Oct. 27, 2008
`
`Supporting
`Documents:
`
`assignment-tm-3877-0582.pdf
`
`Name: MAST CAPITAL MANAGEMENT, LLC
`
`Legal Entity Type: LIMITED LIABILITY COMPANY
`
`Name: LEV PHARMACEUTICALS, INC.
`
`Legal Entity Type: CORPORATION
`
`Address: 122 EAST 42ND STREET
`SUITE 2606
`NEW YORK, NEW YORK 10168
`
`Correspondent
`Name:
`
`Correspondent
`Address:
`
`WILLIAM L. BARTOW
`
`1650 MARKET STREET, SUITE 4900
`ONE LIBERTY PLACE
`PHILADELPHIA, PA 19103
`
`Conveyance: MERGER EFFECTIVE 04082009
`
`Reel/Frame: 4016/0253
`
`Date Recorded: Jul. 02, 2009
`
`Supporting
`Documents:
`
`assignment-tm-4016-0253.pdf
`
`Name: LEV PHARMACEUTICALS, INC.
`
`Legal Entity Type: CORPORATION
`
`Name: LEV DEVELOPMENT CORP.
`
`Legal Entity Type: CORPORATION
`
`Address: 730 STOCKTON DRIVE
`EXTON, PENNSYLVANIA 19341
`
`Correspondent
`Name:
`
`NATALIE A. WARD
`
`Correspondent
`Address:
`
`1111 PENNSYLVANIA AVENUE, NW
`WASHINGTON, DC 20004
`
`Conveyance: CHANGE OF NAME
`
`Reel/Frame: 4016/0259
`
`Date Recorded: Jul. 02, 2009
`
`Supporting
`Documents:
`
`assignment-tm-4016-0259.pdf
`
`Domestic Representative - Not Found
`Assignment 2 of 6
`
`Pages: 4
`
`Assignor
`Execution Date: Oct. 21, 2008
`
`State or Country
`Where Organized:
`
`Assignee
`
`No Place Where Organized Found
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Correspondent
`
`Domestic Representative - Not Found
`Assignment 3 of 6
`
`Pages: 6
`
`Assignor
`Execution Date: Apr. 08, 2009
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Assignee
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Correspondent
`
`Domestic Representative - Not Found
`Assignment 4 of 6
`
`Pages: 6
`
`Assignor
`
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 4
`
`

`

`Name: LEV DEVELOPMENT CORP.
`
`Legal Entity Type: CORPORATION
`
`Name: VIROPHARMA BIOLOGICS, INC.
`
`Legal Entity Type: CORPORATION
`
`Address: 730 STOCKTON DRIVE
`EXTON, PENNSYLVANIA 19341
`
`Correspondent
`Name:
`
`NATALIE A. WARD
`
`Correspondent
`Address:
`
`1111 PENNSYLVANIA AVENUE, NW
`WASHINGTON, DC 20004
`
`Conveyance: SECURITY INTEREST
`
`Reel/Frame: 4621/0517
`
`Date Recorded: Sep. 12, 2011
`
`Supporting
`Documents:
`
`assignment-tm-4621-0517.pdf
`
`Name: VIROPHARMA BIOLOGICS, INC.
`
`Legal Entity Type: CORPORATION
`
`Execution Date: Apr. 08, 2009
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Assignee
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Correspondent
`
`Domestic Representative - Not Found
`Assignment 5 of 6
`
`Pages: 6
`
`Assignor
`Execution Date: Sep. 09, 2011
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Assignee
`Name: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
`
`Legal Entity Type: NATIONAL BANKING ASSOCIATION
`
`State or Country
`Where Organized:
`
`UNITED STATES
`
`Address: 10 SOUTH DEARBORN
`CHICAGO, ILLINOIS 60603
`
`Correspondent
`Name:
`
`Correspondent
`Address:
`
`DUSAN CLARK, ESQ.
`
`SIDLEY AUSTIN LLP
`717 N. HARWOOD ST., SUITE 3400
`DALLAS, TX 75201
`
`Conveyance: RELEASE BY SECURED PARTY
`
`Reel/Frame: 5199/0777
`
`Date Recorded: Jan. 23, 2014
`
`Supporting
`Documents:
`
`assignment-tm-5199-0777.pdf
`
`Name: JPMORGAN CHASE BANK, N.A.
`
`Legal Entity Type: NATIONAL BANKING ASSOCIATION
`
`Name: VIROPHARMA BIOLOGICS, INC.
`
`Legal Entity Type: CORPORATION
`
`Address: 730 STOCKTON DRIVE
`EXTON, PENNSYLVANIA 19341
`
`Correspondent THOMAS E. ZUTIC
`
`Correspondent
`
`Domestic Representative - Not Found
`Assignment 6 of 6
`
`Pages: 5
`
`Assignor
`Execution Date: Jan. 23, 2014
`
`State or Country
`Where Organized:
`
`UNITED STATES
`
`Assignee
`
`State or Country
`Where Organized:
`
`DELAWARE
`
`Correspondent
`
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 5
`
`

`

`Name:
`
`Correspondent
`Address:
`
`500 EIGHTH STREET, NW
`WASHINGTON, DC 20004
`
`Domestic Representative - Not Found
`
`CSL v. Shire, IPR2017-01512
`Shire Ex. 2013, Page 6
`
`